99 related items for PubMed ID: 10228995
1. Pulse cyclophosphamide for steroid-resistant focal segmental glomerulosclerosis.
Rennert WP, Kala UK, Jacobs D, Goetsch S, Verhaart S.
Pediatr Nephrol; 1999 Feb; 13(2):113-6. PubMed ID: 10228995
[Abstract] [Full Text] [Related]
2. Intravenous pulse cyclophosphamide therapy in focal segmental glomerulosclerosis.
Buyukcelik M, Cengiz N, Dursun H, Soran M, Bayazit AK, Noyan A, Anarat A.
Clin Nephrol; 2006 Jan; 65(1):7-12. PubMed ID: 16429836
[Abstract] [Full Text] [Related]
3. Intravenous pulse cyclophosphamide--a new regime for steroid resistant focal segmental glomerulosclerosis.
Gulati S, Kher V.
Indian Pediatr; 2000 Feb; 37(2):141-8. PubMed ID: 10745408
[Abstract] [Full Text] [Related]
4. Pulse cyclophosphamide therapy for steroid-resistant focal segmental glomerulosclerosis in children.
Al Salloum AA.
Ann Saudi Med; 2004 Feb; 24(1):27-30. PubMed ID: 15310010
[Abstract] [Full Text] [Related]
5. Pulse cyclophosphamide therapy in steroid resistant nephrotic syndrome associated with mesangial proliferative glomerulonephritis.
Al Salloum AA.
Saudi J Kidney Dis Transpl; 2004 Feb; 15(2):129-34. PubMed ID: 17642763
[Abstract] [Full Text] [Related]
6. Tacrolimus versus cyclophosphamide in steroid-dependent or steroid-resistant focal segmental glomerulosclerosis: a randomized controlled trial.
Ren H, Shen P, Li X, Pan X, Zhang W, Chen N.
Am J Nephrol; 2013 Feb; 37(1):84-90. PubMed ID: 23343906
[Abstract] [Full Text] [Related]
7. Treatment of focal glomerulosclerosis with pulse steroids and oral cyclophosphamide.
Hari P, Bagga A, Jindal N, Srivastava RN.
Pediatr Nephrol; 2001 Nov; 16(11):901-5. PubMed ID: 11685598
[Abstract] [Full Text] [Related]
8. Intravenous cyclophosphamide in steroid-resistant nephrotic syndrome.
Bajpai A, Bagga A, Hari P, Dinda A, Srivastava RN.
Pediatr Nephrol; 2003 Apr; 18(4):351-6. PubMed ID: 12700961
[Abstract] [Full Text] [Related]
9. Pulse cyclophosphamide therapy in steroid-dependent nephrotic syndrome.
Prasad N, Gulati S, Sharma RK, Singh U, Ahmed M.
Pediatr Nephrol; 2004 May; 19(5):494-8. PubMed ID: 15015070
[Abstract] [Full Text] [Related]
10. Single-centre experience with cyclosporin in 106 children with idiopathic focal segmental glomerulosclerosis.
Mahmoud I, Basuni F, Sabry A, El-Husseini A, Hassan N, Ahmad NS, Elbaz M, Moustafa F, Sobh M.
Nephrol Dial Transplant; 2005 Apr; 20(4):735-42. PubMed ID: 15772265
[Abstract] [Full Text] [Related]
11. Intravenous methylprednisolone and oral alkylating agent therapy of prednisone-resistant pediatric focal segmental glomerulosclerosis: a long-term follow-up.
Tune BM, Kirpekar R, Sibley RK, Reznik VM, Griswold WR, Mendoza SA.
Clin Nephrol; 1995 Feb; 43(2):84-8. PubMed ID: 7736683
[Abstract] [Full Text] [Related]
12. Response to cyclophosphamide in steroid-resistant focal segmental glomerulosclerosis: a reappraisal.
Geary DF, Farine M, Thorner P, Baumal R.
Clin Nephrol; 1984 Sep; 22(3):109-13. PubMed ID: 6488594
[Abstract] [Full Text] [Related]
13. Low-dose methylprednisolone pulse therapy in Chinese children with steroid resistant focal segmental glomerulosclerosis.
Chang JW, Yang LY, Wang HH.
Pediatr Int; 2007 Jun; 49(3):349-54. PubMed ID: 17532834
[Abstract] [Full Text] [Related]
14. Combination of immunosuppressive agents in treatment of steroid-resistant minimal change disease and primary focal segmental glomerulosclerosis.
El-Reshaid K, El-Reshaid W, Madda J.
Ren Fail; 2005 Jun; 27(5):523-30. PubMed ID: 16152989
[Abstract] [Full Text] [Related]
15. Steroid-resistant nephrotic syndrome: long-term evolution after sequential therapy.
Peña A, Bravo J, Melgosa M, Fernandez C, Meseguer C, Espinosa L, Alonso A, Picazo ML, Navarro M.
Pediatr Nephrol; 2007 Nov; 22(11):1875-80. PubMed ID: 17876609
[Abstract] [Full Text] [Related]
16. Treatment of childhood prednisone-resistant nephrotic syndrome and focal segmental glomerulosclerosis with intravenous methylprednisolone and oral alkylating agents.
Griswold WR, Tune BM, Reznik VM, Vazquez M, Prime DJ, Brock P, Mendoza SA.
Nephron; 1987 Nov; 46(1):73-7. PubMed ID: 3600915
[Abstract] [Full Text] [Related]
17. Cyclophosphamide in the treatment of focal segmental glomerulosclerosis.
Martinelli R, Pereira LJ, Silva OM, Okumura AS, Rocha H.
Braz J Med Biol Res; 2004 Sep; 37(9):1365-72. PubMed ID: 15334202
[Abstract] [Full Text] [Related]
18. Clinical course of primary focal segmental glomerulosclerosis (FSGS) in Turkish children: a report from the Turkish Pediatric Nephrology FSGS Study Group.
Beşbaş N, Ozaltin F, Emre S, Anarat A, Alpay H, Bakkaloğlu A, Baskin E, Buyan N, Dönmez O, Düşünsel R, Ekim M, Göko F, Gür-Güven A, Kavukçu S, Mir S, Sönmez F.
Turk J Pediatr; 2010 Sep; 52(3):255-61. PubMed ID: 20718182
[Abstract] [Full Text] [Related]
19. Recurrent focal segmental glomerulosclerosis in pediatric renal transplant recipients: successful treatment with oral cyclophosphamide.
Kershaw DB, Sedman AB, Kelsch RC, Bunchman TE.
Clin Transplant; 1994 Dec; 8(6):546-9. PubMed ID: 7865917
[Abstract] [Full Text] [Related]
20. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
Ehrich JH, Geerlings C, Zivicnjak M, Franke D, Geerlings H, Gellermann J.
Nephrol Dial Transplant; 2007 Aug; 22(8):2183-93. PubMed ID: 17504846
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
